Cargando…
Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas
Ameloblastomas are a group of benign, locally aggressive, recurrent tumors characterized by their slow and infiltrative growth. E-Cadherin and syndecan-1 are cell adhesion molecules related to the behavior of various tumors, including ameloblastomas. Ninety-nine ameloblastoma samples were studied; t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937611/ https://www.ncbi.nlm.nih.gov/pubmed/29850393 http://dx.doi.org/10.1155/2018/9392632 |
_version_ | 1783320657377886208 |
---|---|
author | Carreón-Burciaga, Ramón G. González-González, Rogelio Molina-Frechero, Nelly López-Verdín, Sandra Pereira-Prado, Vanesa Bologna-Molina, Ronell |
author_facet | Carreón-Burciaga, Ramón G. González-González, Rogelio Molina-Frechero, Nelly López-Verdín, Sandra Pereira-Prado, Vanesa Bologna-Molina, Ronell |
author_sort | Carreón-Burciaga, Ramón G. |
collection | PubMed |
description | Ameloblastomas are a group of benign, locally aggressive, recurrent tumors characterized by their slow and infiltrative growth. E-Cadherin and syndecan-1 are cell adhesion molecules related to the behavior of various tumors, including ameloblastomas. Ninety-nine ameloblastoma samples were studied; the expression of E-cadherin and syndecan-1 were evaluated by immunohistochemistry. E-Cadherin and epithelial syndecan-1 were more highly expressed in intraluminal/luminal unicystic ameloblastoma than in mural unicystic ameloblastoma and solid/multicystic ameloblastoma, whereas the stromal expression of syndecan-1 was higher in mural unicystic ameloblastoma and solid/multicystic ameloblastoma. Synchronicity was observed between E-cadherin and epithelial syndecan-1; the expression was correlated with intensity in all cases. There was a strong association between expression and tumor size and recurrence. The evaluation of the expression of E-cadherin and syndecan-1 are important for determining the potential aggressiveness of ameloblastoma variants. Future studies are required to understand how the expression of these markers is related to tumor aggressiveness. |
format | Online Article Text |
id | pubmed-5937611 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-59376112018-05-30 Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas Carreón-Burciaga, Ramón G. González-González, Rogelio Molina-Frechero, Nelly López-Verdín, Sandra Pereira-Prado, Vanesa Bologna-Molina, Ronell Anal Cell Pathol (Amst) Research Article Ameloblastomas are a group of benign, locally aggressive, recurrent tumors characterized by their slow and infiltrative growth. E-Cadherin and syndecan-1 are cell adhesion molecules related to the behavior of various tumors, including ameloblastomas. Ninety-nine ameloblastoma samples were studied; the expression of E-cadherin and syndecan-1 were evaluated by immunohistochemistry. E-Cadherin and epithelial syndecan-1 were more highly expressed in intraluminal/luminal unicystic ameloblastoma than in mural unicystic ameloblastoma and solid/multicystic ameloblastoma, whereas the stromal expression of syndecan-1 was higher in mural unicystic ameloblastoma and solid/multicystic ameloblastoma. Synchronicity was observed between E-cadherin and epithelial syndecan-1; the expression was correlated with intensity in all cases. There was a strong association between expression and tumor size and recurrence. The evaluation of the expression of E-cadherin and syndecan-1 are important for determining the potential aggressiveness of ameloblastoma variants. Future studies are required to understand how the expression of these markers is related to tumor aggressiveness. Hindawi 2018-04-23 /pmc/articles/PMC5937611/ /pubmed/29850393 http://dx.doi.org/10.1155/2018/9392632 Text en Copyright © 2018 Ramón G. Carreón-Burciaga et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Carreón-Burciaga, Ramón G. González-González, Rogelio Molina-Frechero, Nelly López-Verdín, Sandra Pereira-Prado, Vanesa Bologna-Molina, Ronell Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas |
title | Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas |
title_full | Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas |
title_fullStr | Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas |
title_full_unstemmed | Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas |
title_short | Differences in E-Cadherin and Syndecan-1 Expression in Different Types of Ameloblastomas |
title_sort | differences in e-cadherin and syndecan-1 expression in different types of ameloblastomas |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937611/ https://www.ncbi.nlm.nih.gov/pubmed/29850393 http://dx.doi.org/10.1155/2018/9392632 |
work_keys_str_mv | AT carreonburciagaramong differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas AT gonzalezgonzalezrogelio differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas AT molinafrecheronelly differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas AT lopezverdinsandra differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas AT pereirapradovanesa differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas AT bolognamolinaronell differencesinecadherinandsyndecan1expressionindifferenttypesofameloblastomas |